Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05595161 · ClinicalTrials.gov registry record · NA
Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity
A NA study of Obesity, Childhood, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 3
- Study locations
NCT05595161: Active NA study of Obesity, Childhood, sponsored by Yale University.
NCT05595161 is a NA study of Obesity, Childhood that is active but no longer recruiting, run by Yale University. The registered enrollment target is 182 participants, below the 340-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (46% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05595161, a NA study of Obesity, Childhood, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will evaluate the effectiveness of the Bright Bodies intervention in improving body mass index (BMI) among 7-13 year-old children with obesity simultaneously with the impact of the implementation strategy on adoption, reach, fidelity, cost, and maintenance of the intervention in three heterogenous settings serving patients disproportionately affected by obesity.
Primary Outcome
Change in %BMIp95, calculated from height and weight. A negative percentage indicates that the participant's BMI has decreased since enrollment.
Conditions Studied
Interventions
- BEHAVIORAL Bright Bodies
Study Locations (3)
Alabama
- University of Alabama at Birmingham - Birmingham
California
- University of California San Francisco - San Francisco
Maine
- Maine Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2026-01-08 |
| Phase | NA |
What the registry record for NCT05595161 still lists
NCT05595161 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 340-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 1 intervention - of which Bright Bodies is the first listed.
NCT05595161 reports a single indexed study location in Alabama, California, Maine.
Frequently Asked Questions
What is clinical trial NCT05595161 about?
NCT05595161 is a clinical study titled "Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity". This study will evaluate the effectiveness of the Bright Bodies intervention in improving body mass index (BMI) among 7-13 year-old children with obesity simultaneously with the impact of the implementation strategy on adoption, reach, fidelity, cost, and maintenance of the intervention in three het...
What is the current status of trial NCT05595161?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 182 participants. The study started on 2022-10-11. Estimated completion is 2026-01-08.
What conditions does trial NCT05595161 study?
This clinical trial studies the following conditions: Obesity, Childhood.
What interventions are being tested in trial NCT05595161?
The interventions under investigation include: Bright Bodies (BEHAVIORAL).
Who is sponsoring clinical trial NCT05595161?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05595161 being conducted?
This trial has 3 study locations across Alabama, California, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05595161's enrollment target sits among peer trials
182 25th of 53 higher than 29 of 53 other Obesity, Childhood trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Childhood trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
RECRUITING · NA
-
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
RECRUITING · NA
-
Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents
RECRUITING · NA
-
Food Genetics Behavior Study
RECRUITING · NA
-
Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity
RECRUITING · NA
-
Family, Responsibility, Education, Support, and Health for Food Responsiveness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI